1Levy D, Crarrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study [J]. N Engl J Med, 1990,322: 1561-1566.
2Yamazaki T, Komuro I, Zou Y, et al. Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both α1 and β-adrenoceptors [J]. Circulation, 1997,95: 1260-1268.
3Yamazakl T, Komuro I, Zou Y, et al. Protein kinase A and protein kinase C synergistically activate the raf-1 kinase/mitogen-activated protein kinase cascade in neonatal rat cardiomyocytes [J]. J Mol Cell Cardiol, 1997,29 : 2491-2501.
4Yamazaki T, Shiojima I, Komuro I, et al. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction [ J ]. Journal of hypertension, 1994, 12 ( suppl 9 ) : S23-S27.
3Mathew J.Reduction of cardiovascular risk by regression of electrocardiographic markersof left vertricular hypertrophy by angiotension-converting enzyme inhibition ramipril[ J ] . Circulation,2001,104: 1615-1621.
5Levy D, Crarrison RJ, Savage DD, et al. Prognostic implications of echocardiographically delennuned leftventricular mass in the Framingham Heart Study [J]. N Engl J Med, 1990 ; 322:1561.
6Messerli F H, Ketelhut R. Left ventricular hypertrophy: A pressure- independent cardiovascular risk factor [ J ]. J Cardiovasc Pharmacol. 1993,22 (suppl 1 ): s7 - s13.
7Schmieder R E, Messerli F H. Hypertension and the heart[J].J Hum Hypertens, 2000,14:597 - 604.
8Michel P, Guy Michel V. Signalling by protein kinase C isoform in the heart[J]. Mol Cell Biochem, 1996,157:65- 72.
